Oxcarbazepine may induce psychotic symptoms in Parkinson's disease

Norbert Kovacs, Ferenc Nagy, Istvan Balas, Samuel Komoly, Jozsef Janszky

Research output: Contribution to journalArticle

5 Citations (Scopus)


Although there is a relatively high prevalence of both idiopathic Parkinson's disease (PD) and epilepsy in the elderly population, and PD occurs more frequently in people with epilepsy, there are no studies investigating the efficacy and tolerability of antiepileptic drugs (AEDs) in people with PD. We describe the case of a 71-year-old man with PD who experienced several seizures. The initiation of antiepileptic treatment with oxcarbazepine (OXC) provoked a severe, long-lasting psychotic state. The patient had previously experienced similar psychotic episodes during dopamine agonist therapy. Because recent animal studies have proven that OXC and its active metabolite exert important dopamine- and serotonin-promoting effects in the limbic area, we assumed that in our case the OXC-induced psychosis was mediated by the dopaminergic system. We concluded that OXC should be used with care in cases of a constellation of PD and epilepsy because of its possible psychiatric side effects. The dopaminergic effect of OXC and its active metabolite might also play an ambivalent, but important role in the treatment of alcohol addiction and bipolar disorder; therefore, further studies are required to investigate its psychopharmacological aspects.

Original languageEnglish
Pages (from-to)492-493
Number of pages2
JournalEpilepsy and Behavior
Issue number3
Publication statusPublished - Apr 1 2008


  • Antiepileptic drugs
  • Epilepsy
  • Oxcarbazepine
  • Parkinson's disease
  • Psychosis

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Behavioral Neuroscience

Fingerprint Dive into the research topics of 'Oxcarbazepine may induce psychotic symptoms in Parkinson's disease'. Together they form a unique fingerprint.

  • Cite this